Antihistamines work by blocking histamine, a chemical your immune system releases during an allergic reaction, from binding to receptors on your cells. Without that binding, the chain of events that produces sneezing, itching, swelling, and a runny nose gets interrupted before symptoms fully develop. Most over-the-counter allergy medications target one specific receptor type, called H1, which is responsible for the classic allergy symptoms most people recognize.
What Histamine Does in Your Body
Histamine is stored mainly inside mast cells, a type of immune cell found in high concentrations in your skin, lungs, and gut lining. When your immune system identifies something as a threat (pollen, pet dander, dust mites), it produces antibodies that attach to mast cells. The next time that allergen shows up, it links to those antibodies, and the mast cell essentially bursts open in a process called degranulation, dumping histamine and other inflammatory chemicals into surrounding tissue.
This process can also be triggered without antibodies. Insect venom, certain medications, and even physical vibration can cause mast cells to release histamine through entirely separate pathways. That’s why some people develop hive-like reactions to stimuli that aren’t technically allergens.
Once released, histamine latches onto receptors scattered across different tissues. Your body has four types of histamine receptors, each doing something different. H1 receptors drive the familiar allergy symptoms: itchy eyes, nasal congestion, hives, and swelling. H2 receptors control stomach acid production. H3 receptors in the brain regulate the release of histamine itself along with other brain chemicals like serotonin and dopamine. H4 receptors guide immune cells toward sites of inflammation. When people say “antihistamine,” they almost always mean a drug targeting H1 receptors, though H2 blockers are widely used for heartburn and acid reflux.
Blocking the Receptor
For decades, scientists described antihistamines as simple blockers: the drug sits on the H1 receptor and physically prevents histamine from attaching. The reality is more nuanced. Most H1 antihistamines are actually “inverse agonists,” meaning they don’t just block histamine from landing on the receptor. They actively push the receptor into its inactive state.
H1 receptors have a small amount of baseline activity even when no histamine is around. An inverse agonist locks the receptor into its off position, reducing even that background signaling. This is different from a pure blocker (called a neutral antagonist), which would only prevent histamine from binding without dialing down the receptor’s resting activity. The practical result is that inverse agonists can suppress allergic inflammation a bit more thoroughly, which is one reason antihistamines can help with chronic hives even between flare-ups.
First Generation vs. Second Generation
The biggest practical difference between antihistamine types comes down to whether they cross into the brain. First-generation antihistamines, like diphenhydramine (the active ingredient in Benadryl), pass freely through the blood-brain barrier. Once in the brain, they block H1 receptors there too, which is what causes drowsiness, slowed reaction times, and the foggy feeling many people associate with allergy medication. These drugs are rapidly absorbed, reaching peak blood levels in one to three hours, with half-lives of roughly 3 to 12 hours.
Second-generation antihistamines, like cetirizine (Zyrtec) and loratadine (Claritin), were designed to stay mostly out of the brain. They achieve this partly through a protein pump called P-glycoprotein, which actively pushes them back out of brain tissue. Cetirizine and fexofenadine (Allegra) penetrate the brain poorly regardless of pump activity, making them especially unlikely to cause drowsiness. Loratadine does reach the brain to some degree, but the pump keeps levels low enough that most people don’t notice sedation. These drugs have longer half-lives of 8 to 24 hours, which is why they work with once-daily dosing instead of every four to six hours.
Why the Difference Matters Beyond Drowsiness
First-generation antihistamines don’t only block histamine receptors in the brain. They also interfere with acetylcholine, a chemical messenger involved in memory, attention, and muscle control. This anticholinergic effect causes dry mouth, blurred vision, constipation, and urinary retention. In older adults, the cognitive impact is significant: chronic use of anticholinergic drugs is associated with a 40% higher risk of developing mild cognitive impairment compared to people who don’t take them. The American Geriatrics Society lists first-generation antihistamines as potentially inappropriate for older adults specifically because of these cognitive risks. Second-generation drugs largely avoid this problem because they don’t have strong anticholinergic properties.
Why Timing Makes a Difference
Antihistamines are more effective when they’re already in your system before histamine gets released. Once histamine has bound to receptors and triggered inflammation, an antihistamine can only prevent additional binding. It can’t reverse the swelling and fluid leakage already underway. This is why allergists often recommend starting antihistamines a week or two before allergy season rather than waiting for symptoms to hit.
Research on prophylactic dosing supports this approach. In one study of 220 patients at risk for allergic reactions, those who received an antihistamine beforehand had significantly fewer allergic reactions than control groups. The principle extends to seasonal allergies: if pollen counts are rising and you know your triggers, taking your antihistamine in the morning before heading outside gives it time to occupy receptors before mast cells start releasing histamine.
What Antihistamines Can and Cannot Do
Antihistamines are effective against symptoms driven specifically by histamine: itching, sneezing, hives, watery eyes, and a runny nose. They’re less effective at relieving nasal congestion, because stuffiness is driven more by other inflammatory chemicals that mast cells release alongside histamine. That’s why many allergy products combine an antihistamine with a decongestant.
They also don’t address the underlying immune overreaction. Your body still produces antibodies, your mast cells still degranulate, and all the other inflammatory chemicals still get released. Antihistamines simply mute the histamine portion of that response. For people with severe allergies, this is why treatments like immunotherapy (allergy shots or sublingual tablets) exist: they aim to retrain the immune system rather than just block one messenger.
Antihistamines designed for H2 receptors work on an entirely different problem. Because H2 receptors on stomach lining cells drive acid production, H2 blockers like famotidine reduce heartburn and acid reflux. They have no meaningful effect on allergy symptoms, and standard allergy antihistamines have no meaningful effect on stomach acid. The two classes target different receptors in different tissues, even though both are technically “antihistamines.”